Tag archives: Donna Harrison

Ella vs. RU-486: Similarities and Differences

by Family Research Council

October 5, 2010

Last week, as the abortion industry celebrated the 10-year anniversary of the FDA approval of RU-486, we learned the grim news that two additional women have died from complications related to the abortion drug. In total, since its approval in 2000, 12 women (and approximately a million babies) have died as a result of RU-486 in the U.S.

As we’ve previously reported, ella, which is chemically and functionally similar to RU-486, was approved by the FDA on August 13th. Continuing our series educating health care workers and the general public about ella, in this short youtube clip we again hear from Dr. Donna Harrison, OB-GYN and president of the American Association of Pro-life Obstetricians and Gynecologists (AAPLOG).

In this clip Dr. Harrison simply describes the differences and similarities between ella and RU-486. She explains how both drugs block progesterone, alter the placenta and what that means for implanted fetuses.

Part II from Gerald Nadal on Ella

by Chris Gacek

September 17, 2010

Dr. Gerald Nadal has posted the second part of his article discussing the approval of Ella (ulipristal). The first story discussed Ella’s abortifacient properties. In the second installment, Nadal discusses the lack of transparency characteristic of the FDA’s handling of the Ella drug application. Go here for his analysis which cites to a filing by the American Association of Obstetricians and Gynecologists (AAPLOG) under the leadership of Dr. Donna Harrison. (Nadal provides a link to the AAPLOG filing.)

Archives